Efficacy and pharmacodynamic effects of bosutinib (SKI-606), a Src/Abl inhibitor, in freshly generated human pancreas cancer xenografts
Messersmith, W. A., Rajeshkumar, N.V., Tan, A. C., Wang, X. F., Diesl, V., Choe, S. E., Follettie, M., Coughlin, C., Boschelli, F., Garcia-Garcia, E., Lopez-Rios, F., Jimeno, A., Hidalgo, M.Volume:
8
Language:
english
Journal:
Molecular Cancer Therapeutics
DOI:
10.1158/1535-7163.MCT-09-0075
Date:
June, 2009
File:
PDF, 732 KB
english, 2009